Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease

Reviews in the Neurosciences

Volumn 17, Issue 5, 2006, Pages 497-523

  Puzzo, Daniela ^a,b   Palmeri, Agostino ^b   Arancio, Ottavio ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Alzheimer's disease; Amyloid beta peptide; Hippocampal long term potentiation; Memory; Nitric oxide cGMP CREB pathway; Synaptic plasticity

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; AMYL NITRITE; AMYLOID; AMYLOID BETA PROTEIN[25-35]; CHOLINESTERASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC GMP; DIZOCILPINE; GLYCERYL TRINITRATE; INDUCIBLE NITRIC OXIDE SYNTHASE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SILDENAFIL;

ALZHEIMER DISEASE; ANGINA PECTORIS; DRUG MECHANISM; DRUG TARGETING; HEADACHE; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THORAX PAIN;

EID: 33751535253     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2006.17.5.497     Document Type: Review

References (248)

1. Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER, Bourtchouladze R Genetic demonstration of a role for PKA in the late phase of LTP and hippocampus-based long-term memory. Cell 1997; 88: 615-626.
2. Agullo L, Garcia A. Characterization of noradrenaline-stimulated cyclic GMP formation in brain astrocytes in culture. Biochem J 1992; 288: 619-624.
3. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593-615.
4. Allen MT, Steinmetz JE. A nitric oxide synthase inhibitor delays the formation of learning-related neural activity in the cerebellar interpositus nucleus during rabbit eyelid conditioning. Pharmacol Biochem Behav 1996; 53: 147-153.
5. Andreasen N, Sjogren M, Blennow K. CSF markers for Alzheimer's disease: total tau, phospho-tau and Aβ42. World J Biol Psychiatry 2003; 4: 147-155.
6. Applegate MD, Kerr DS, Landfield PW. Redistribution of synaptic vesicles during long-term potentiation in the hippocampus. Brain Res 1987; 401: 401-406.
7. Arancio O, Antonova I, Gambaryan S, Lohmann SM, Wood J, Lawrence D, Hawkins RD. Presynaptic cGMP-dependent protein kinase contributes to long-lasting potentiation in cultured hippocampal neurons. J Neurosci 2001; 21: 143-149.
8. Arancio O, Kandel ER, Hawkins RD. Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons. Nature 1995; 376: 74-80.
9. Arancio O, Kiebler M, Lee CJ, Lev-Ram V, Tsien RY, Kandel ER, Hawkins RD. Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell 1996; 87: 1025-1035.
10. Arispe N, Pollard HB, Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci USA 1993; 90: 10573-10577.
11. Arispe N, Rojas E, Pollard HB. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium. Proc Natl Acad Sci USA 1993; 90, 567-571.
12. Bagetta G, Corasaaiti MT, Melino G, Paoletti AM, Finazzi-Agro A, Nistico G. Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem Biophys Res Commun 1993; 197: 1132-1139.
13. Baltrons MA, Pedraza CE, Heneka MT, Garcia A. β-Amyloid peptides decrease guanylyl cyclase expression in astroglial cells. Neurobiol Dis 2002; 10: 139-149.
14. Bannerman DM, Chapman PF, Kelly PA, Butcher SP, Morris RG. Inhibition of nitric oxide synthase does not impair spatial learning. J Neurosci 1994; 14: 7404-7414.
15. Baratti CM, Boccia MM. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 1999; 10: 731-737.
16. Baratti CR, Kopf SR. A nitric oxide synthase inhibitor impairs memory storage in mice. Neurobiol Learn Mem 1996; 65: 197-201.
17. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 1997; 276: 2042-2045.
18. Basun H, Nilsberth C, Eckman C, Lannfelt L, Younkin S. Plasma levels of Aβ42 and Aβ40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine. Dement Geriatr Cogn Disord 2002; 14: 156-160.
19. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-748.
20. Beher D, Graham SL. Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease. Expert Opin Investig Drugs 2005; 14: 1385-1409.
21. Berezovska O, Lleo A, Herl LD, Frosch MP, Stern EA, Bacskai BJ, Hyman BT. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 2005; 25: 3009-3017.
22. Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH. Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. NeuroReport 1996; 7: 585-588.
23. Bemabeu R, Schroder N, Quevedo J, Cammarota M, Izquierdo I, Medina JH. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. NeuroReport 1997; 8: 2221-2224.
24. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973; 232: 331-356.
25. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39.
26. Bliss TVP, Douglas RM, Errington ML, Lynch MA. Correlation between long-term potentiation and release of endogenous amino acids from dentate gyrus of anaesthetized rats. J Physiol 1986; 377: 391-408.
27. Blokland A, de Vente J, Prickaerts J, Honig W, Markerink-van Ittersum M, Steinbusch H. Local inhibittion of hippocampal nitric oxide synthase does not impair place learning in the Morris water escape task in rats. Eur J Neurosci 1999; 11: 223-232.
28. Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W, de Vente J, Prickaerts J, Blokland A, Koenig G. Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 2004; 47: 1081-1092.
29. Bohme GA, Bon C, Lemaire M, Reibaud M, Piot O, Stutzmann JM, Doble A, Blanchard JC. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci USA 1993; 90: 9191-9194.
30. Bohme GA, Bon C, Stutzmann J-M, Doble A, Blanchard J-C. Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol 1991; 199: 379-381.
31. Boje KM, Arora PK. Microglialproduced nitric oxide and reactive nitrogen oxides mediates neuronal cell death. Brain Res 1992; 587: 250-256.
32. Bon C, Bohme GA, Doble A, Stutzmann J-M, Blanchard J-C. A role for nitric oxide in long-term potentiation. Eur J Neurosci 1992; 4: 420-424.
33. Bon CL, Garthwaite J. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway. Eur J Neurosci 2001; 14: 585-594.
34. Bonhoeffer T, Staiger V, Aertsen A. Synaptic plasticity in rat hippocampal slice cultures: local "Hebbian" conjunction of pre- and postsynaptic stimulation leads to distributed synaptic enhancement. Proc Natl Acad Sci USA 1989; 86: 8113-8117.
35. Bonkale WL, Winblad B, Ravid R, Cowburn RF. Reduced nitric oxide responsive guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease. Neurosci Lett 1995; 187: 5-8.
36. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994; 79: 59-68.
37. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-718.
38. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc Natl Acad Sci USA 1990; 87:692-685.
39. Brunton L. On the use of nitrite of amyl in angina pectoris. Lancet 1867; ii: 97-98.
40. Buchs PA, Muller D. Induction of long-term potentiation is associated with major ultrastructural changes of activated synapses. Proc Natl Acad Sci USA 1996; 93: 8040-8045.
41. Burgaud JL, Riffaud JP, Del Soldato P. Nitric-oxide releasing molecules: a new class of drugs with several major indications. Curr Pharm Des 2002; 8: 201-213.
42. Calzal L, Giardino L, Ceccatelli S. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. NeuroReport 1993; 4: 627-630.
43. Ceccatelli S, Eriksson M. The effect of lactation on nitric oxide synthase gene expression. Brain Res 1993; 625: 177-179.
44. Chain DG, Casadio A, Schacher S, Hegde AN, Valbrun M, Yamamoto N, Goldberg AL, Bartsch D, Kandel ER, Schwartz JH. Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia. Neuron 1999; 22: 147-156.
45. Chalimoniuk M, Strosznajder JB. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol Chem Neuropathol 1998; 35: 77-95.
46. Chang WP, Koelsch G, Wong S, Downs D, Da H, Weerasena V, Gordon B, Devasamudram T, Bilcer G, Ghosh AK, Tang J. In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors. J Neurochem 2004; 89: 1409-1416.
47. Chapman PF, Atkins CM, Allen MT, Haley JE, Steinmetz JE. Inhibition of nitric oxide synthesis impairs two different forms of learning. NeuroReport 1992; 3: 567-570.
48. Chetkovich DM, Klann E, Sweatt JD. Nitric oxide synthase-independent long-term potentiation in area CA1 of hippocampus. NeuroReport 1993; 4: 919-922.
49. Churcher I, Beher D. Gamma-secretase as a therapeutic target for the treatment of Alzheimer's disease. Curr Pharm Des 2005; 11: 3363-3382.
50. Ciani E, Guidi S, Bartesaghi R, Contestabile A. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 2002; 82: 1282-1289.
51. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992; 360: 672-674.
52. Citron M. Beta-secretase inhibition for the treatment of Alzheimer's disease-promise and challenge. Trends Pharmacol Sci 2004; 25: 92-97.
53. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 2005; 8: 79-84.
54. Coan EJ, Collingridge GL. Characterization of an N-methyl-D-aspartate receptor component of synaptic transmission in rat hippocampal slices. Neuroscience 1987; 22: 1-8.
55. Collingridge GL, Kehl SJ, McLennan H. Excitatory aminoacids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol 1983; 334: 33-46.
56. Comery TA, Martone RL, Aschmies S, Atchison KP, Diamantidis G, Gong X, Zhou H, Kreft AF, Pangalos MN, Sonnenberg-Reines J, Jacobsen JS, Marquis KL. Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease. J Neurosi 2005; 25: 8898-8902.
57. Corbin JD, Francis SH. Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 1999; 274: 13729-13732.
58. Cullen WK, Suh YH, Anwyl R, Rowan MJ. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. NeuroReport 1997; 8: 3213-3217.
59. Davis S, Vanhoutte P, Pages C, Caboche J, Laroche S. The MAPK/ERK cascade targets both Elk-1 and c-AMP response elements-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci 2000; 20: 4563-4572.
60. Desmond NL, Levy WB. Morphological correlates of long-term potentiation imply the modification of existing synapses, not synaptogenesis, in the hippocampal dentate gyrus. Synapse 1990; 5: 139-143.
61. Diamond DM, Dunwiddie TV, Rose GM. Characteristics of hippocampal primed burst potentiation in vitro and in the awake rat. J Neurosci 1988; 8: 4079-4088.
62. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 2001; 21: 4125-41233.
63. Dineley KT, Xia X, Bui D, Sweatt JD, Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 2002; 277: 22768-22780.
64. Drummond GI. Cyclic nucleotides in the nervous system. Adv Cyclic Nucleotide Res 1983; 15: 373-494.
65. Edwards FA. LTP: a structural model to explain the inconsistencies. Trends Neurosci 1995; 18: 250-255.
66. English JD, Sweatt JD. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 1997; 272: 19103-19116.
67. Errington ML, Lynch MA, Bliss TV. Long-term potentiation in the dentate gyrus: induction and increased glutamate release are blocked by D(-)aminophosphonovalerate. Neuroscience 1987; 20: 279-284.
68. Etcheberrigaray R, Ito E, Kim CS, Alkon DL. Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast Kq channels. Science 1994; 264: 276-279.
69. Etcheberrigaray R, Ito E, Oka K, Tofel-Grehl B, Gibson GE, Alkon DL. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 8209-8213.
70. Fezoui Y, Teplow DB. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J Biol Chem 2002; 277: 36948-36954.
71. Fifkova E, Vanharreveld A. Long-lasting morphological changes in dendritic spines of dentate granular area following stimulation of the entorhinal area. J Neurocytol 1997; 6: 211-230.
72. Fin C, da Cunha C, Bromberg E, Schmitz PK, Bianchin M, Medina JH, Izquierdo I. Experiments suggesting a role for nitric oxide in the hippocampus in memory processes. Neurobiol Learn Mem 1995; 63: 113-115.
73. Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A. Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 2005; 6: 85-89.
74. Fink CC, Meyer T. Molecular mechanism of CaMKII activation in neuronal plasticity. Curr Opin Neurobiol 2002; 12: 293-299.
75. Francis SH, Corbin JD. Structure and function of cyclic nuclectide-dependent protein kinases. Annu Rev Physiol 1994; 56: 237-272.
76. Frey U, Krug M, Reymann KG, Matthies H. Anisomycin, an inhibitor of protein synthesis, blocks late phase of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res 1988; 452: 57-65.
77. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
78. Gandy S, Martins RN, Buxbaum J. Molecular and cellular basis for anti-amyloid therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 2003; 17: 259-266.
79. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 2005; 115: 1121-1129.
80. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine and autocrine ligands. Cell 1992; 71: 1-4.
81. Garthwaite J, Boulton CL. Nitric oxide signalling in the central nervous system. Annu Rev Physiol 1995; 57: 683-706.
82. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385-388.
83. Gentile MT, Vecchione C, Maffei A, Aretini A, Marino G, Poulet R, Capobianco L, Selvetella G, Lembo G. Mechanisms of soluble beta-amyloid impairment of endothelial function. J Biol Chem 2004; 279: 48135-48142.
84. Ghosh AK, Kumaragurubaran N, Tang J. Recent developments of structure based beta-secretase inhibitors for Alzheimer's disease. Curr Top Med Chem 2005; 5: 1609-1622.
85. Giuffrida Stella AM. The new role for an old enzyme studied by A. Clementi in neurodegenerative disorders [in Italian]. It J Biochem 2000; 49: 1-101.
86. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 2004; 114: 1624-1634.
87. Gooney MA, Shaw K, Kelly A, O'Mara SM, Lynch MA. Long-term potentiation and spatial learning are associated with increased phosphorylation of TrkB and extracellular signal regulated kinase (ERK) in the dentate gyrus: evidence for a role for brain-derived neurotrophic factor. Behav Neurosci 2002; 116: 455-463.
88. Greenstein YJ, Pavlides C, Winson J. Long-term potentiation in the dentate gyrus is preferentially induced at theta rhythm periodicity. Brain Res 1988; 438: 331-334.
89. Gribkoff VK, Lum-Ragan JT. Evidence for nitric oxide synthase inhibitor-sensitive and insensitive hippocampal synaptic potentiation. J Neurophysiol 1992; 68: 639-642.
90. Gudi T, Casteel DE, Vinson C, Boss GR, Pilz RB. NO activation of fos promoter elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activation. Oncogene 2000; 19: 6324-6333.
91. Gudi T, Huvar I, Meinecke M, Lohmann SM, Boss GR, Pilz RB. Regulation of gene expression by cGMP-dependent protein kinase. J Biol Chem 1996; 271: 4597-4600.
92. Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B. Inducible nitric oxide synthase and arginino-succinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett 2002; 322: 121-125.
93. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 1992; 359: 322-325.
94. Haley JE, Malen PL, Chapman PF. Nitric oxide synthase inhibitors block long-term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices. Neurosci Lett 1993; 160: 85-88.
95. Haley JE, Wilcox GL, Chapman PF. The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992; 8: 211-216.
96. Hawkins RD. NO honey, I don't remember. Neuron 1996; 16: 465-467.
97. He W, Barrow CJ. The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. Biochemistry 1999; 38: 10871-10877.
98. Hebb DO. The Organization of Behavior: A Neuropsychological Theory. New York: Wiley, 1949.
99. Hering C. Glonoine, a new medicine for headache etc. Am J Homeopathy 1849; 4: 3.
100. Houslay MD. PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol 2001; 69: 249-315.
101. Hu SC, Chrivia J, Ghosh A. Regulation of CBP-mediated transcription by neuronal calcium signaling. Neuron 1999; 22: 799-808.
102. Huang Y, Kandel ER. Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. Learn Mem 1994; 1: 74-82.
103. Huang Y-Y, Nguyen PV, Abel T, Kandel ER. Long-lasting forms of synaptic potentiation in the mammalian hippocampus. Learn Mem 1996; 3: 74-85.
104. Huber G, Martin JR, Loffler J, Moreau JL. Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach. Brain Res 1993; 603: 348-352.
105. Hussein I. The potential for BACE1 inhibitors in the treatment of Alzheimer's disease. IDrugs 2004; 7: 653-658.
106. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 1998; 21: 869-883.
107. Ishida A, Furukawa K, Keller JN, Mattson MP. Secreted form of β-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices. NeuroReport 1997; 8: 2133-2137.
108. Itoh A, Akaike T, Sokabe M, Nitta A, Iida R, Olariu A, Yamada K, Nabeshima T. Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. Eur J Pharmacol 1999; 382: 167-175.
109. Izquierdo LA, Vianna M, Barrosw DM, Souza TM, Arenghi P, Sant'Anna MK, Rodrigues C, Medina JH, Izquierdo I. Short- and long-term memory are differentially affected by metabolic inhibitors given into hippocampus and enthorinal cortex. Neurobiol Learn Mem 2000; 73: 141-149.
110. Izumi Y, Zorumski CF. Nitric oxide and long-term synaptic depression in the rat hippocampus. NeuroReport 1993; 4: 1131-1134.
111. Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN. Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mire. J Neurosci 2002; 22: 2246-2254.
112. Kalaria RN. Vascular factors in Alzheimer's disease. Int Psychogeriatr 2003; 15 (Suppl 1): 47-52.
113. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733-736.
114. Kantor DB, Lanzrein J, Stary SJ, Sandoval GM, Smith WB, Sullivan BM, Davidson N, Schuman EM. A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science 1996; 274: 1744-1748.
115. Katzoff A, Ben-Gedalya T, Susswein AJ. Nitric oxide is necessary for multiple memory processes after learning that a food is inedible in Aplysia. J Neurosci 2002; 22: 9581-9594.
116. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004; 279: 46363-46366.
117. Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Mimmack M, Ohkura S. Formation of olfactory memories mediated by nitric oxide. Nature 1997; 388: 670-674.
118. Kirchner L, Weitzdoerfer R, Hoeger H, Url A, Schmidt P, Engelmann M, Villar SR, Fountoulakis M, Lubec G, Lubec B. Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. Nitric Oxide 2004; 11: 316-330.
119. Klein WL, Krafft GA, Finch CE. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 2001; 24: 219-224.
120. Knowles RG, Palaeios M, Palmer RMI, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989; 89: 5159-5162.
121. Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990; 533: 315-320.
122. Kowalska MA, Badellino K. β-Amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem Biophys Res Commun 1994; 205: 1829-1835.
123. Koylu EO, Kanit L, Taskiran D, Dagci T, Balkan B, Pogun S. Effects of nitric oxide synthase inhibition on spatial discrimination learning and central DA2 and mACh receptors. Pharmacol Biochem Behav 2005; 81: 32-40.
124. Kuenzi F, Rosahl TW, Morton RA, Fitzjohn SM, Collingridge GL, Seabrook GR. Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodiesterase type 6 (PDE6). Brain Res 2003; 967: 144-151.
125. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 1996; 271: 4077-4081.
126. Larson J, Wong D, Lynch G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res 1986; 368: 347-350.
127. Law A, O'Donnel J, Gauthier S, Quirion R. Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats. Neuroscience 2002; 112: 267-275.
128. Liao D, Hessler NA, Malinow R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slices. Nature 1995; 375: 400-404.
129. Lisman J, Harris KM. Quantal analysis and synaptic anatomy-integrating two views of hippocampal plasticity. Trends Neurosci 1993; 16: 141-147.
130. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, De Jonge HR. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 1997; 22: 307-312.
131. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002; 35: 605-623.
132. Lu YF, Kandel ER, Hawkins RD. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 1999; 19: 10250-10261.
133. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004; 84: 87-136.
134. Lynch MA. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog Neurobiol 1998; 56: 571-589.
135. Ma L, Zablow L, Kandel ER, Siegelbaum SA. Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures. Nat Neurosci 1999; 2: 24-30.
136. Ma S, Cornford ME, Vahabnezhad I, Wei S, Li X. Responses of nitric oxide synthase expression in the gracile nucleus to sciatic nerve injury in young and aged rats. Brain Res 2000; 855: 124-131.
137. 2+ homeostasis and cell death. J. Neurosci 1995; 15: 6239-6249.
138. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12: 376-389.
139. Mattson MP, Cheng B, Smith-Swintosky VL. Mechanisms of neurotrophic factor protection against calcium-and free radical-mediated excitotoxic injury: implications for treating neurodegenerative disorders. Exp Neurol 1993; 124: 89-95.
140. Mattson MP, Guo ZH, Geiger JD. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem 1999; 73: 532-537.
141. Mattson MP. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 1997; 77: 1081-1132.
142. McCarty MF. Vascular nitric oxide may lessen Alzheimer's risk. Med Hypotheses 1998; 51: 465-476.
143. McGahon B, Maguire C, Kelly A, Lynch MA. Activation of p42 mitogen-activated protein kinase by arachidonic acid and trans-1-amino- cyclopenthyl-1,3-dicarboxylate impacts on long-term potentiation in dentate gyrus in the rat: analysis of age related changes. Neuroscience 1999; 90: 1167-1175.
144. Meshul CK, Hopkins WF. Presynaptic ultrastructural correlates of long-term potentiation in the CA1 subfield of the hippocampus. Brain Res 1990; 514: 310-319.
145. Monfort P, Munoz MD, Koseko E, Felipo V. Long-term potentiation in hippocampus involves sequential active-tion of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J Neurosci 2002; 22: 10116-10122.
146. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 1997; 66: 807-822.
147. Morris RG, Anderson E, Lynch GS. Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986; 319: 774-776.
148. Muller U. Inhibition of nitric oxide synthase impairs a distinct form of long-term memory in the honeybee, Apis mellifera. Neuron 1996; 16: 541-549.
149. Murphy DD, Segal M. Morphological plasticity of dentritic spines in central neurons is mediated by activation of cAMP response elements binding protein. Proc Natl Acad Sci USA 1997; 94: 1482-1487.
150. Murphy S, Minor RL Jr, Welk G, Harrison DG. Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide. J Neurochem 1990; 55: 349-351.
151. Murrell W. Nitro-glycerine as a remedy for angina pectoris. Lancet 1879; i: 80-81.
152. Nagao S, Kitazawa H, Osanai R, Hiramatsu T. Acute effects of tetrahydrobiopterin on the dynamic characteristics and adaptability adaptability of vestibulo-ocular reflex in normal and flocculus lesioned rabbits. Neurosci Lett 1997; 231: 41-44.
153. Nakagami Y, Nishimura S, Murasugi T, Kubo T, Kaneko I, Meguro M, Marumoto S, Kogen H, Koyama K, Oda T. A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro. Br J Pharmacol 2002; 137: 676-682.
154. Nguyen PV, Abel T, Kandel ER. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994; 265: 1104-1107.
155. Nguyen PV, Kandel ER. Brief theta-burst stimulation induces a transcription-dependent late phase of LTP requiring cAMP in area CA1 of the mouse hippocampus. Learn Mem 1997; 4: 230-243.
156. Ninan I, Arancio O. Presynaptic CaMKII is necessary for synaptic plasticity in cultured hippocampal neurons. Neuron 2004; 42: 129-141.
157. O'Dell TJ, Hawkins RD, Kandel E, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 1991; 88: 11285-11289.
158. Ohki K, Yoshida K, Hagiwara M, Harada T, Takamura M, Ohashi T, Matsuda H, Imaki J. Nitric oxide induces c-fos gene expression via cyclic AMP response element binding protein (CREB) phosphorylation in rat retinal pigment epithelium. Brain Res 1995; 696: 140-144.
159. Otmakhova NA, Otmakhov N, Mortenson LH, Lisman JE. Inhibition of the cAMP pathway decreases early long-term potentiation at CA1 hippocampal synapses. J Neurosci 2000; 20: 4446-4451.
160. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
161. Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90: 10962-10966.
162. Paris D, Town T, Parker T, Humphrey J, Mullan M. β-Amyloid vasoactivity and proinflammation in microglia can be blocked by cGMP-elevating agents. Ann NY Acad Sci 2000; 903: 446-450.
163. Paris D, Town T, Parker TA, Tan J, Humphrey J, Crawford F, Mullan M. Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism. Exp Neurol 1999; 157: 211-221.
164. Parks JK, Smith TS, Trimmer PA, Bennett JP Jr, Parker WD Jr. Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem 2001; 76: 1050-1056.
165. Pasquier F, Leys D. Blood pressure and Alzheimer's disease. Rev Neurol (Paris) 1998; 154: 743-751.
166. Podlisny MB, Walsh DM, Amarante P, Ostaszewski BL, Stimson ER, Maggio JE, Teplow DB, Selkoe DJ. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 1998; 37: 3602-3611.
167. Price JM, Hellermann A, Hellermann G, Sutton ET. Aging enhances vascular dysfunction induced by the Alzheimer's peptide beta-amyloid. Neurol Res 2004; 26: 305-311.
168. Prickaerts J, de Vente J, Honig W, Steinbusch HW, Blokland A. cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. Eur J Pharmacol 2002; 436: 83-87.
169. Prickaerts J, Steinbusch HW, Smits JF, de Vente J. Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast. Eur J Pharmacol 1997; 33: 125-136.
170. Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP- responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 2005; 25: 6887-6897.
171. Qiu W, Ferreira A, Miller C, Koo C, Selkoe D. Cell-surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner. J Neurosci 1995; 15: 2157-2167.
172. Rashid A. The efficacy and safety of PDE5 inhibitors. Clin Cornerstone 2005; 7: 47-56.
173. 2+ ionophore raise cyclic GMP levels in a neuronal cell line via formation of nitric oxide. Br J Pharmacol 1990; 101: 722-726.
174. 2+. Eur J Biochem 1990; 189: 547-552.
175. Renbaum P, Levy-Lahad E. Monogenic determinants of familial Alzheimer's disease: presenilin-2 mutations. Cell Mol Life Sci 1998; 54: 910-919.
176. 2+ release from cyclic ADP-ribose-sensitive stores. J Neurophysiol 1999; 82: 1569-1576.
177. Rickard NS, Ng KT, Gibbs ME. Further support for nitric oxide-dependent memory processing in the day-old chick. Neurobiol Learn Mem 1998; 69: 79-86.
178. Roberson ED, Sweatt JD. Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation. J Biol Chem 1996; 271: 30436-30441.
179. Roberts SB. Gamma-secretase inhibitors and Alzheimer's disease. Adv Drug Deliv Rev 2002; 54: 1579-1588.
180. Robertson JD, Bonaventura J, Kohm A, Hiscat M. Nitric oxide is necessary for visual learning in Octopus vulgaris. Proc Biol Sci 1996; 263: 1739-1743.
181. Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 1996; 271: 20631-20635.
182. Rose GM, Dunwiddie TV. Induction of hippocampal long-term potentiation using physiologically patterned stimulation. Neurosci Lett 1986; 69: 244-248.
183. Rossor MN, Newman S, Frackowiak RS, Lantos P, Kennedy AM. Alzheimer's disease families with amyloid precursor protein mutations. Ann NY Acad Sci 1993; 695: 198-202.
184. Russo C, Dolcini V, Salis S, Venezia V, Zambrano N, Russo T, Schettini G. Signal transduction through tyrosine-phosphorylated Cterminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. J Biol Chem 2002; 277: 35282-35288.
185. Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S. Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 1995; 14: 457-466.
186. Salbaum JM, Ruddle FH. Embryonic expression pattern of amyloid protein precursor suggests a role in differentiation of specific subsets of neurons. J Exp Zool 1994; 269: 116-127.
187. Samama B, Boehm N. Inhibition of nitric oxide synthase impairs early olfactory associative learning in newborn rats. Neurobiol Learn Mem 1999; 71: 219-231.
188. Schaad NC, Vanecek J, Schulz PE. Photoneural regulation of rat pineal nitric oxide synthase. J Neurochem 1994; 62: 2496-2499.
189. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177.
190. Schlossmann J, Feil R, Hofmann F. Signaling through NO and cGMP-dependent protein kinases. Ann Med 2003; 35: 21-27.
191. Schultheiss D, Muller SV, Nager W, Stief CG, Schlote N, Jonas U, Asvestis C, Johannes S, Munte TF. Central effects of sildenafil (viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol 2001; 19: 46-50.
192. Schuman EM, Madison DV. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 1991; 254: 1503-1506.
193. Schuman EM, Madison DV. Locally distributed synaptic potentiation in the hippocampus. Science 1994; 263: 532-536.
194. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003; 43: 545-584.
195. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-791.
196. Selkoe DJ. Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 1994; 17: 489-517.
197. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 2000; 924: 17-25.
198. Sherrington CS. The Integrative Action of the Nervous System. New York: Charles Scribner's Sons, 1906.
199. Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998; 20: 727-740.
200. Simons M, De Strooper B, Multhaup G, Tienari PJ, Dotti CG, Beyreuther K. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J Neurosci 1996; 16: 899-908.
201. Singh N, Parle M. Sildenafil improves acquisition and retention of memory in mice. Indian J Physiol Pharmacol 2003; 47: 318-324.
202. Smith CC, Stanyer L, Betteridge DJ. Soluble beta-amyloid (Aβ) 40 causes attenuation or potentiation of noradrenaline-induced vasoconstriction in rats depending upon the concentration employed. Neurosci Lett 2004; 367: 129-132.
203. Smith S, Dringenberg HC, Bennett BM, Thatcher GR, Reynolds JN. A novel nitrate ester reverses the cognitive impairment caused by scopolamine in the Morris water maze. NeuroReport 2000; 11: 3883-3886.
204. Soderling SH, Beavo JA. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 2000; 12: 174-179.
205. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ER. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 1996; 87: 1015-1023.
206. Spires TL, Hyman BT. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2005; 2: 423-437.
207. St George-Hyslop PH. Molecular genetics of Alzheimer's disease. Biol Psychiatry 2000; 47: 183-199.
208. Stanciu M, Radulovic J, Spiess J. Phosphorylated cAMP response element binding protein in the mouse brain after fear conditioning: relationship to Fos production. Brain Res Mol Brain Res 2001; 94: 15-24.
209. Suhara T, Magrane J, Rosen K, Christensen R, Kim HS, Zheng B, McPhie DL, Walsh K, Querfurth H. Aβ42 generation is toxic to andothelial cells and inhibits eNOS function through an Akt/GSK-3β signaling-dependent mechanism. Neurobiol Aging 2003; 24: 437-451.
210. Susswein AJ, Katzoff A, Miller N, Hurwitz I. Nitric oxide and memory. Neuroscientist 2004; 10: 153-162.
211. Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 1994; 200: 1598-1603.
212. Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W. The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 1996; 3: 159-168.
213. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998; 20: 709-726.
214. Taylor SS, Yang J, Wu J, Haste NM, Radzio-Andzelm E, Anand G. PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta 2004; 1697: 259-269.
215. Teyke T. Nitric oxide, but not serotonin, is involved in acquisition of food-attraction conditioning in the snail Helix pomatia. Neurosci Lett 1996; 206: 29-32.
216. Thatcher GR, Bennett BM, Dringenberg HC, Reynolds JN. Novel nitrates as NO mimetics directed at Alzheimer's disease. J Alzheimers Dis 2004; 6 (Suppl): S75-884.
217. Thatcher GR, Bennett BM, Reynolds JN. Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease. Curr Alz Res 2005; 2: 171-182.
218. Thompson LA, Bronson JJ, Zusi FC. Progress in the discovery of BACE inhibitors. Curr Pharm Des 2005; 11: 3383-3404.
219. 3H]AMPA binding in rat hippocampus. Brain Res 1992; 573: 228-234.
220. Tong L, Thornton PL, Balazs R, Cotman CW. Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J Biol Chem 2001; 276: 17301-17306.
221. Tran MH, Yamada K, Olariu A, Mizuno M, Ren XA, Nabeshima T. Amyloid-β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 2001; 15: 1407-1409.
222. Traylor TG, Sharma VS. Why NO? Biochemistry 1992; 31: 2847-2849.
223. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 2000; 20: 1386-1392.
224. Vallebuona F, Raiteri M. Age-related changes in NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis. Eur J Neurosci 1995; 7: 694-701.
225. Vassar R. Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Deliv Rev 2002; 54: 1589-1602.
226. Venturini G, Colasanti M, Persichini T, Fioravanti E, Ascensi P, Palomba L, Cantoni O, Musci G. β-Amyloid inhibits NOS activity by subtracting NADPH availability. FASEB J 2002; 16: 1970-1972.
227. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. Amyloid β peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 2002; 99: 13217-13221.
228. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416: 535-539.
229. Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, Selkoe DJ. Certain inhibitors of synthetic amyloid beta-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J Neurosci 2005; 25: 2455-2462.
230. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 2000; 39: 10831-10839.
231. Wang HG, Lu FM, Jin I, Udo H, Kandel ER, de Vente J, Walter U, Lohmann SM, Hawkins RD, Antonova I. Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins. Neuron 2005; 45: 389-403.
232. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid-β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 2004; 24: 3370-3378.
233. Wenk GL, McGann-Gramling K, Hauss-Wegrzyniak B, Ronchetti D, Maucci R, Rosi S, Gasparini L, Ongini E. Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J Neurochem 2004; 89: 484-493.
234. Williams JH, Li Y-G, Nayak A, Errington ML, Murphy KPSJ, Bliss TVP. The suppression of long-term potentiatioh in rat hippocampus by inhibitors of nitric oxide synthase is temperature and age dependent. Neuron 1993; 11: 877-884.
235. Wirtz-Brugger F, Giovanni A. Guanosine 3′,5′-cyclic monophosphate mediated inhibition of cell death induced by nerve growth factor withdrawal and beta-amyloid: protective effects of propentofylline. Neuroscience 2000; 99: 737-750.
236. Wong ST Athos J, Figueroa XA, Pineda VV, Schaefer ML, Chavkin CC, Muglia LJ, Storm DR. Calcium stimulated adenylyl cyclase activity is critical for hippocampus-dependent long term memory and late phase LTP. Neuron 1999; 23: 787-798.
237. Wu J, Anwyl R, Rowan MJ. β-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur J Pharmacol 1995; 284: R1-3.
238. Xie Z, Wei M, Morgan TE, Fabrizio P, Han D, Finch CE, Longo VD. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J Neurosci 2002; 22: 3484-3492.
239. Xu M, Lai MT, Huang Q, DiMuzio-Mower J, Castro JL, Harrison T, Nadin A, Neduvelil JG, Shearman MS, Shafer JA, Gardell SJ, Li YM. γ-Secretase: characterization and implication for Alzheimer disease therapy. Neurobiol Aging 2002; 23: 1023-1030.
240. Yamada K, Noda Y, Hasegawa T, Komori Y, Nikai T, Sugihara H, Nabeshima T. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J Pharmacol Exp Ther 1996; 276: 460-466.
241. Yin JC, Tully T. CREB and the formation of long-term memory. Curr Opin Neurobiol 1996; 6: 264-268.
242. Yin JC, Wallach JS, Del Vecchio M, Wilder EL, Zhou H, Quinn WG, Tully T. Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila. Cell 1994; 79: 49-58.
243. Younkin SG. Evidence that A beta 42 is the real culprit in Alzheimer's disease. Ann Neurol 1995; 37: 287-288.
244. Zakharenko SS, Zablow L, Siegelbaum SA. Visualization of changes in presynaptic function during long-term synaptic plasticity. Nat Neurosci 2001; 4: 711-717.
245. Zhang S, Chen J, Wang S. Spatial learning and memory induce of nitric oxide-producing neurons in rat brain. Brain Res 1998; 801: 101-106.
246. Zhuo M, Hu Y, Schultz C, Kandel ER, Hawkins RD. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 1994; 368: 635-639.
247. Zhuo M, Small SA, Kandel ER, Hawkins RD. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in the hippocampus. Science 1993; 260: 1946-1950.
248. Zou LB, Yamada K, Tanaka T, Kameyama T, Nabeshima T. Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. Neuropharmacology 1998; 37: 323-330.